The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - BMS Brazil; MSD Oncology; Roche Molecular Diagnostics
Consulting or Advisory Role - MSD Oncology
Molecular profiling of ER+ metastatic breast cancers to reveal association of genomic alterations with acquired resistance to CDK4/6 inhibitors.
 
Pedram Razavi
Consulting or Advisory Role - Novartis
Research Funding - GRAIL (Inst); Illumina (Inst)
 
Carlos Henrique Dos Anjos
No Relationships to Disclose
 
David N Brown
No Relationships to Disclose
 
Li Qing
No Relationships to Disclose
 
Christina Ping
No Relationships to Disclose
 
Joshua Herbert
No Relationships to Disclose
 
Jodecy Colon
No Relationships to Disclose
 
Dazhi Liu
No Relationships to Disclose
 
Maiya Mao
No Relationships to Disclose
 
Larry Norton
Honoraria - Advanced Breast Cancer International Consensus Conference; Bluprint Oncology Concepts; Celgene; Context Therapeutics; MCI Breast Cancer Symposium
Consulting or Advisory Role - Advanced Breast Cancer International Consensus Conference; Bluprint Oncology Concepts; Celgene; Context Therapeutics; MCI Breast Cancer Symposium
Travel, Accommodations, Expenses - Advanced Breast Cancer International Consensus Conference; Celgene; MCI Breast Cancer Symposium
 
Maurizio Scaltriti
Stock and Other Ownership Interests - Medendi Medical Travel
Honoraria - ADC Therapeutics; Menarini
Consulting or Advisory Role - Menarini; The Bioscience Institute
Research Funding - Daiichi Sankyo; Immunomedics; Menarini; Puma Biotechnology; TargImmune Therapeutics
Patents, Royalties, Other Intellectual Property - PI3K INHIBITORS AND USES THEREOF, SK2018-110
 
David B. Solit
Stock and Other Ownership Interests - Loxo
Consulting or Advisory Role - Illumina; Intezyne Technologies; Loxo; Pfizer; Vividion Therapeutics
Travel, Accommodations, Expenses - Merck KGaA
 
Mark E. Robson
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca; McKesson; Merck; Pfizer
Research Funding - Abbvie (Inst); AstraZeneca (Inst); InVitae (Inst); Medivation (Inst); Myriad Genetics (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Jorge S. Reis-Filho
Consulting or Advisory Role - Genentech/Roche; Goldman Sachs; Invicro; Paige.AI; Ventana Medical Systems; Volition RX
 
Komal L. Jhaveri
Consulting or Advisory Role - ADC Therapeutics; AstraZeneca; Jounce therapeutics; Novartis; Pfizer; Spectrum Pharmaceuticals; Taiho Pharmaceutical
Research Funding - ADC Therapeutics (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); Genentech (Inst); Novartis (Inst); Novita Pharmaceuticals (Inst); Pfizer (Inst)
Other Relationship - Jounce Therapeutics; Novartis; Pfizer; Taiho Pharmaceutical
 
Sarat Chandarlapaty
Consulting or Advisory Role - Context Therapeutics; Lilly; Novartis; Sermonix Pharmaceuticals
Research Funding - Daiichi Sankyo (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Novartis; Sun Pharma